LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
Senate
Bills
SB652
US
US Federal Senate Bill SB652
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal Senate Bill SB652
Introduced
2/20/25
Refer
2/20/25
Caption
Protecting Patients from Deceptive Drug Ads Act
Congress_id
119-S-652
Policy_area
Health
Introduced_date
2025-02-20
Latest US SB652 Activity
View All Events: US 2025-2026 Regular Session SB652
Companion Bills
No companion bills found.
Previously Filed As
US SB2712
Protecting Patient Access to Physician-Administered Drugs Act; enact.
US HB17
Protecting Patient Access to Physician-Administered Drugs Act; create.
US H2472
Protecting patient safety regarding non-FDA approved drugs
US S1497
Protecting patient safety regarding non-FDA approved drugs
US HB06870
An Act Addressing Patients' Prescription Drug Costs.
US HB1090
Protections Against Deceptive Pricing Practices
US SB2699
Patient's Right to Informed Health Care Choices Act & prohibitions against deceptive advertising by providers; delete repealers on.
US HB7980
Protecting Americans from Unsafe Drugs Act of 2026
US HB6906
Protecting Patients from Rehab Fraud Act of 2025
US SB2667
Nurse practitioners; authorize to dispense legend drugs to patients.
Similar Bills
No similar bills found.